|
2025
|
Invention
|
Compound as dgkζ inhibitor. Disclosed is a compound as a DGKζ inhibitor. Specifically, disclosed ... |
|
|
Invention
|
Novel protein degrader and antibody-protein degrader conjugate. A novel protein degrader and an a... |
|
2024
|
Invention
|
Compound which acts as myt1 inhibitor. Disclosed are a class of compounds which act as MYT1 inhib... |
|
|
Invention
|
Hdac1/2 selective inhibitor and use thereof. Disclosed in the present invention are an HDAC1/2 se... |
|
|
Invention
|
Compound as dgkζ inhibitor. A class of compounds as DGKζ inhibitors. Specifically, the present in... |
|
|
Invention
|
Parp inhibitor, and preparation method therefor and medical use thereof. Disclosed in the present... |
|
|
Invention
|
Compounds as myt1 inhibitors. Disclosed in the present invention are compounds as MYT1 inhibitors... |
|
|
Invention
|
Cbl-b inhibitor. A class of Cbl-b inhibitors. Specifically, the present invention relates to a co... |
|
|
Invention
|
Thiazole compounds as dgkζ inhibitors. Disclosed in the present invention are thiazole compounds ... |
|
|
Invention
|
Compounds used as dgk zeta inhibitors. Disclosed are a class of compounds used as DGK zeta inhibi... |
|
|
Invention
|
Compound acting as myt1 inhibitor. Disclosed in the present invention is a compound acting as an ... |
|
|
Invention
|
Kif18a inhibitor. Disclosed in the present invention is a KIF18A inhibitor. Specifically, the pre... |
|
2023
|
Invention
|
Hdac inhibitor and use thereof. An HDAC inhibitor and the use thereof. Specifically, the present ... |
|
|
Invention
|
Pharmaceutical composition for treatment of cancer. Disclosed is a pharmaceutical composition for... |
|
|
Invention
|
Tricyclic pi3kα inhibitor, preparation method therefor, and pharmaceutical use thereof. Disclosed... |
|
|
Invention
|
Compounds as sumo activating enzyme inhibitors. Disclosed in the present invention are compounds ... |
|
|
Invention
|
Ulk inhibitors. Disclosed are a class of ULK inhibitors. Specifically, the present invention rela... |
|
|
Invention
|
Compound as inhibitor for sumo activating enzyme. Provided are a compound represented by general ... |
|
|
Invention
|
Compounds as her2 inhibitors. A class of compounds as HER2 inhibitors. Specifically, the present ... |
|
|
Invention
|
Kif18a inhibitor.
Disclosed in the present invention is a class of KIF18A inhibitors. Specifical... |
|
|
Invention
|
Kif18a inhibitor. Disclosed in the present invention is a class of KIF18A inhibitors. Specificall... |
|
|
Invention
|
Kif18a inhibitor. A type of KIF18A inhibitor. Specifically provided are a compound represented by... |
|
|
Invention
|
Compound as fak inhibitor and use thereof. Disclosed in the present invention are a compound as a... |
|
|
Invention
|
Compound as fak inhibitor and use thereof.
Disclosed in the present invention are a compound as ... |
|
|
Invention
|
Novel egfr inhibitor. Disclosed is a novel EGFR inhibitor. Specifically, the present invention re... |
|
|
Invention
|
Picolinamide parp inhibitor, and preparation method therefor and medical use thereof. Disclosed a... |
|
|
Invention
|
Fused ring compounds serving as hpk1 inhibitors. Provided is a class of fused ring compounds that... |
|
2022
|
Invention
|
Compound as fak inhibitor and use thereof. Disclosed are a class of compounds as FAK inhibitors a... |
|
|
Invention
|
Kif18a inhibitor. The present invention discloses a KIF18A inhibitor. Specifically, the pre... |
|
|
Invention
|
Kif18a inhibitor. Disclosed are a class of KIF18A inhibitors, and specifically disclosed are a co... |
|
|
Invention
|
Compounds used as src inhibitors.
Disclosed in the present invention are a class of compounds as... |
|
|
Invention
|
Compound used as src inhibitor. A class of compounds used as an Src inhibitor. Specifically, the ... |
|
|
Invention
|
Fused ring compound as hpk1 inhibitor. Provided is a class of fused ring compounds as an HPK1 inh... |
|
|
Invention
|
Fused ring compound as hpk1 inhibitor. A fused ring compound as an HPK1 inhibitor. Specifically, ... |
|
|
Invention
|
Fgfr2 inhibitor, preparation method therefor, and pharmaceutical use thereof. A compound represen... |
|
|
Invention
|
Fused ring compound acting as shp2 inhibitor.
Disclosed are fused cyclic compounds as SHP2 inhib... |
|
|
Invention
|
Naphthyridine derivative as atr inhibitor and method for preparing same.
Disclosed are a naphthy... |
|
|
Invention
|
1,2,4-triazolone derivative as dhodh inhibitor, and preparation method therefor and use thereof. ... |
|
|
Invention
|
Idh mutant inhibitor and use thereof.
Disclosed in the present invention are a class of IDH muta... |
|
|
Invention
|
Fused cyclic compound as wee-1 inhibitor, preparation method therefor and use thereof.
Disclosed... |
|
|
Invention
|
Parp inhibitor containing piperazine structure, preparation method therefor and pharmaceutical us... |
|
|
Invention
|
Pyrimidine compound as wee-1 inhibitor.
The present invention discloses a pyrimidine compound as... |
|
|
Invention
|
Fused ring compound as wee-1 inhibitor.
The present invention discloses a fused cyclic compound ... |
|
2021
|
Invention
|
Novel camptothecin derivative, composition comprising same and use thereof.
The present inventio... |
|
|
Invention
|
Idh mutant inhibitor and use thereof.
The present invention relates to a compound of general for... |
|
|
Invention
|
Pyrazolo[3,4-d]pyrimidin-3-one derivative as wee-1 inhibitor.
The present invention relates to a... |
|
|
Invention
|
New pyrazine compound.
The present invention relates to a compound as represented by general for... |
